Option chain shows key data for Coloplast's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Coloplast.

Coloplast (OTC:CLPBY) Stock, Option Chain

Coloplast

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Short Ideas

Trading Ideas

CLPBY

On Tuesday, shares of Coloplast (OTC: CLPBY) experienced volatile short activity. After the activity, the stock price went up +0.59% to $13.18.

The overall sentiment for CLPBY has been Bullish.

Short Volatility Alert: Coloplast

ASHTY

ENGGY

ESLOY

KRYAY

LRLCY

Nestle Sponsored representing Registered Shares Series B

NSRGY

RHHBY

WTKWY

In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that have proven to reward shareholders with rising dividends over a long period.

15 European Dividend Aristocrats To Diversify Your Portfolio

News

Intraday Update

Markets

Movers

ABBRF

ACGL

ADBE

ADSK

ADVM

AEHR

AEMMY

AFGC

AGNC

AMRC

AMWD

AMXEF

ANSS

ARCAY

ARCVF

ARDC

ARNC

ATVI

AVXL

AZMTF

AZRE

BABYF

BLDP

BLDR

BRSGF

BWXT

CACI

CALA

CCYC

CDNS

CELH

CEVA

CGEN

CHDN

CHTR

CLGX

CNNE

COST

CRMT

CROL

CSLLY

CTAS

CVNA

CWEN

CWEN-A

DBOEY

DGIF

DNNGY

DOCU

DOGEF

DOOO

DOOR

Stocks That Hit 52-Week Highs On Wednesday

Coloplast AS

Warning: CLPBY is at high risk of cutting its dividend

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Coloplast (OTCMKTS:<a href="https://investorplace.com/stock-quotes/clpby-stock-quote/">CLPBY</a>) just reported results for the third quarter of 2024.<ul><li>Coloplast reported earnings per share of 8 cents.</li><li>The company reported revenue of $993.51 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/clpby-stock-earnings-coloplast-for-q3-of-2024/">CLPBY Stock Earnings: Coloplast Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CLPBY Stock Earnings: Coloplast Reported Results for Q3 2024

Coloplast A/S (CLPBF) Q4 2024 Earnings Call Transcript

Harding Loevner International Equity ADR Q3 2024 Report

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Coloplast (OTCMKTS:<a href="https://investorplace.com/stock-quotes/clpby-stock-quote/">CLPBY</a>) just reported results for the third quarter of 2024.<ul><li>Coloplast reported earnings per share of 8 cents.</li><li>The company reported revenue of $993.51 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/clpby-stock-earnings-coloplast-for-q3-of-2024/">CLPBY Stock Earnings: Coloplast Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Comments

Coloplast

Coloplast (CLPBY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga